MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 871038-72-1
Formula C20H20FKN6O5MW 482.5Research-use catalog entryCOA/SDS by request

Raltegravir Potassium

CAS Number: 871038-72-1

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 g
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 g
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
25 g
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: IFUKBHBISRAZTF-UHFFFAOYSA-MC20H20FKN6O5 | MW 482.5

Chemical Absolute Identifiers

CAS Number

871038-72-1

PubChem CID

23668479

Molecular Formula

C20H20FKN6O5

Molecular Weight

482.5 g/mol

Exact Mass

482.111627

InChIKey

IFUKBHBISRAZTF-UHFFFAOYSA-M

IUPAC Name

potassium 4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-olate

SMILES String

Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+]

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Raltegravir Potassium (CAS 871038-72-1) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C20H20FKN6O5 and molecular weight 482. 50 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Human immunodeficiency virus type 1 integrase (Human immunodeficiency virus 1) — 3 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Human immunodeficiency virus type 1 integrase

Human immunodeficiency virus 1 · SINGLE PROTEIN · 3 qualifying assays · 3 documents · best pChEMBL 8.48

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Raltegravir Potassium

Names & Synonyms

Raltegravir Potassium SaltIsentressMK0518 POTASSIUMMK-0518 POTASSIUMRaltegravir monopotassium salt
Show all synonyms
Isentress hdL000900612 POTASSIUM SALTL-000900612 POTASSIUM SALTDUTREBIS COMPONENT RALTEGRAVIR POTASSIUMN-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide monopotassium saltPotassium, Raltegravirpotassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-olateRaltegravir (potassium)Raltegravir (potassium salt)Raltegravir ( K salt) API4-Pyrimidinecarboxamide, N-((4-fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-, monopotassium saltRaltegravir potassium [USAN]Isentress (TN)Raltegravir potassium [USAN:JAN]871038-72-1 (potassium)
External Identifiers
EC NUMBER: 682-461-3DSSTOX SUBSTANCE ID: DTXSID501007339CHEMBL ID: CHEMBL518520UNII: 43Y000U234KEGG ID: D07133NCI THESAURUS CODE: C73823RXCUI: 1235585
Literature & Patent References
DOI 10.1016/j.bmc.2017.09.0061-Hydroxypyrido[2,3-d]pyrimidin-2(1H)-ones as novel selective HIV integrase inhibitors obtained via privileged substructure-based compound libraries.PMID 289510951-Hydroxypyrido[2,3-d]pyrimidin-2(1H)-ones as novel selective HIV integrase inhibitors obtained via privileged substructure-based compound libraries.DOI 10.1021/jm400645wCarbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).PMID 23845180Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).DOI 10.1016/j.ejmech.2012.02.015Hydroxyl may not be indispensable for raltegravir: Design, synthesis and SAR Studies of raltegravir derivatives as HIV-1 inhibitors.DOI 10.1016/j.ejmech.2012.04.020Design, synthesis and antiviral activity of novel pyridazines.PMID 22369862Hydroxyl may not be indispensable for raltegravir: Design, synthesis and SAR Studies of raltegravir derivatives as HIV-1 inhibitors.PMID 22608761Design, synthesis and antiviral activity of novel pyridazines.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

Bms-707035CAS 729607-74-3
Dolutegravir SodiumCAS 1051375-19-9
DolutegravirCAS 1051375-16-6
(2Z)-3-{[(4-Fluorophenyl)methyl](methoxy)carbamoyl}-2-hydroxyprop-2-enoic acidCAS 543730-41-2

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylateCAS 1018142-22-76-cyclopropyl-1-(2,2-difluoroethyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acidCAS 1018144-00-72-(3-Cyclopropyl-6-isopropyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid

RFQ questions for CAS 871038-72-1

What are the key identifiers for Raltegravir Potassium (CAS 871038-72-1)?

Raltegravir Potassium is identified by CAS 871038-72-1, with molecular formula C20H20FKN6O5, molecular weight 482.5, InChIKey IFUKBHBISRAZTF-UHFFFAOYSA-M.

Does CAS 871038-72-1 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Human immunodeficiency virus type 1 integrase. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 871038-72-1?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Raltegravir Potassium?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 871038-72-1 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.